Valuation Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
|
Market Closed -
TEL AVIV STOCK EXCHANGE
10:29:06 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 11,090.00 ILa | +0.64% |
|
+2.59% | +9.91% |
| 08-19 | Aurinia Settles Patent Lawsuit With Teva; Shares Rise After Hours | MT |
| 08-19 | Teva Pharmaceutical Industries Insider Sold Shares Worth $680,291, According to a Recent SEC Filing | MT |
Company Valuation: Teva Pharmaceutical Industries Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 8,835 | 10,129 | 11,703 | 25,006 | 35,807 | 43,034 | - | - |
| Change | - | 14.65% | 15.54% | 113.68% | 43.19% | 20.19% | - | - |
| Enterprise Value (EV) 1 | 29,713 | 28,540 | 28,310 | 39,489 | 49,057 | 54,912 | 51,645 | 48,874 |
| Change | - | -3.95% | -0.81% | 39.49% | 24.23% | 11.94% | -5.95% | -5.37% |
| P/E | 21.1x | -4.3x | -20.9x | -15.2x | 25.8x | 49.5x | 20.3x | 15.9x |
| PBR | 0.86x | 1.28x | 1.56x | 4.64x | 4.96x | 4.96x | 3.7x | 3.12x |
| PEG | - | 0x | 0.3x | -0x | -0x | -1.3x | 0x | 0.6x |
| Capitalization / Revenue | 0.56x | 0.68x | 0.74x | 1.51x | 2.07x | 2.6x | 2.49x | 2.38x |
| EV / Revenue | 1.87x | 1.91x | 1.79x | 2.39x | 2.84x | 3.31x | 2.98x | 2.71x |
| EV / EBITDA | 6.05x | 6.21x | 5.88x | 8.26x | 9.25x | 12.2x | 9.24x | 8.13x |
| EV / EBIT | 6.75x | 6.9x | 6.49x | 9.12x | 10x | 13.8x | 10.1x | 8.72x |
| EV / FCF | 126x | 27.4x | 33.6x | 52.7x | 42.7x | 25x | 16.2x | 12.6x |
| FCF Yield | 0.79% | 3.65% | 2.97% | 1.9% | 2.34% | 4% | 6.18% | 7.97% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.38 | -2.12 | -0.5 | -1.45 | 1.21 | 0.7454 | 1.82 | 2.318 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 15,878 | 14,925 | 15,846 | 16,544 | 17,258 | 16,582 | 17,304 | 18,056 |
| EBITDA 1 | 4,911 | 4,598 | 4,818 | 4,781 | 5,305 | 4,503 | 5,589 | 6,012 |
| EBIT 1 | 4,401 | 4,139 | 4,361 | 4,329 | 4,905 | 3,981 | 5,106 | 5,607 |
| Net income 1 | 417 | -2,353 | -559 | -1,639 | 1,410 | 1,140 | 2,337 | 2,727 |
| Net Debt 1 | 20,878 | 18,411 | 16,607 | 14,483 | 13,250 | 11,877 | 8,611 | 5,840 |
| Reference price 2 | 8.01 | 9.12 | 10.44 | 22.04 | 31.21 | 36.93 | 36.93 | 36.93 |
| Nbr of stocks (in thousands) | 1,103,007 | 1,110,645 | 1,120,971 | 1,134,592 | 1,147,283 | 1,165,296 | - | - |
| Announcement Date | 2/9/22 | 2/8/23 | 1/31/24 | 1/29/25 | 1/28/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.74x | 12.95x | 26.26x | 0.55% | 1,119B | |
| 30.06x | - | - | 1.99% | 651B | |
| 33.82x | 7.82x | 16.26x | 2.59% | 468B | |
| 20.93x | 4.96x | 12.28x | 2.66% | 374B | |
| 22.59x | 5.81x | 14.4x | 2.75% | 302B | |
| 21.46x | 4.4x | 12.56x | 2% | 259B | |
| 27.79x | 7.17x | 12.73x | 2.3% | 238B | |
| 13.71x | 4.87x | 10.23x | 3.75% | 208B | |
| -44.65x | 6.45x | 25.18x | 2.26% | 181B | |
| Average | 17.94x | 6.80x | 16.24x | 2.32% | 422.21B | |
| Weighted average by Cap. | 25.52x | 8.51x | 18.71x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
- Valuation Teva Pharmaceutical Industries Limited
Select your edition
All financial news and data tailored to specific country editions
